Breast cancer patients take anti-oxidants
Posted on: Monday, 8 June 2009, 16:44 CDT
Many women with breast cancer take anti-oxidants while undergoing cancer treatment, even though the consequences are unknown, U.S. researchers learned.
The study, published online ahead of print of the July 15 issue of the journal Cancer, found almost 70 percent of the women used high doses of anti-oxidants, defined as higher than the amount contained in a Centrum multivitamin. Women who took high doses also were more likely to be using tamoxifen and to have a history of eating more fruits and vegetables, using herbal products and engaging in mind-body practices.
Heather Greenlee of the Columbia University Mailman School of Public Health in New York and colleagues said many breast cancer patients believe anti-oxidant supplements will protect them from the side effects of breast cancer treatment, help prevent recurrence of the disease and improve their overall health.
Greenlee's study is based on 764 patients who completed a follow-up interview and provided information on anti-oxidant supplement use.
Among these patients, 86.8 percent reported receiving chemotherapy, radiation or hormone therapy for breast cancer.
Given the common use of anti-oxidant supplements during breast cancer treatment, often at high doses and in conjunction with other complementary therapies, future research should address the effects of anti-oxidant supplementation on breast cancer outcomes, including whether anti-oxidants affect treatment toxicities, treatment efficacy, cancer recurrence and survival,
the study authors said in a statement.
Source: United Press International
Related Articles
- NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines
- Nursing Research Grants Available to Improve Treatment of Patients With Auto-Immune Diseases and Cancer
- Infinity Initiates Clinical Development of IPI-493, Its Oral Anti-Chaperone Agent, in Patients With Advanced Solid Tumors; Initiation of Phase 1 Expands Infinity's Leading Hsp90 Inhibitor Portfolio
- St. Louis Cancer and Breast Institute to Get New AccuBoost System for Breast Cancer
- MedImmune Advances Potential Treatment for Patients With Lupus
- Bionovo's Publication Tagged As 'Critical Trial' By Leading Journal: Breast Cancer Research and Treatment
- Anti-Radiation Treatment Studies Funded
- Swiss Researchers Report on Promising New Compounds for Cancer Detection and Treatment
- Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study Report No. 27
- Results of Phase IIa Study Show That Reverset Has Potential to Reduce HIV Viral Load in Treatment-Experienced Patients
User Comments (0)

RSS Feeds